Product Images Budesonide Inhalation

This text presents data on the mean change from baseline in nighttime asthma symptoms for patients undergoing different treatments over a 12-week period. The treatments included a placebo and three different doses (0.25mg, 0.5mg, and 1.0mg) of a medication administered once daily. The results show that all three medication doses led to statistically significant reductions in nighttime asthma symptoms compared to the placebo. The p-values suggest that the 0.25mg dose was the most effective treatment with the lowest p-value of 0.001.*

The text describes a chart that shows the mean change from baseline in nighttime asthma symptoms over a 12 week period. The chart displays the results from a placebo and two different dosages of a medication. The medication dosages are 0.25 mg and 0.5 mg, both taken twice daily. The chart indicates that both medication dosages resulted in statistically significant reductions in nighttime asthma symptoms compared to placebo, with p-values of 0.022 and 0.021 for the two dosages.*

The text provides data on the mean change from baseline for nighttime asthma symptoms for different dosage levels of a medication over a 12-week period. The medication was administered at different doses, once or twice daily, and placebo was also included. The p-values are provided for each dosage level.*

This appears to be a mix of different pieces of text without a clear context. Therefore, it's not possible to generate a useful description.*